Demographics and natural history of HIV-1-infected spontaneous controllers of viremia
Authors:
- 15 May 2017
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 31 (8) , 1091-1098
Abstract
Objectives: HIV-1-infected persons spontaneously controlling viremia without treatment (SCV) are rare. Sex and race effects on prevalence and outcome are poorly defined, and it is unclear whether SCV qualitatively or quantitatively differs from typical infection. These issues are examined in this article. Design: Medical records of 46 524 persons receiving outpatient care for HIV-1 infection were reviewed. Of these, 29 811 had adequate viremia testing for SCV screening. Methods: SCV was defined as at least three consecutive plasma viremia measurements + T-cell levels during SCV were compared between demographic subgroups and persons who maintained or lost SCV during observation. Results: In total, 53 persons (0.18%) met SCV criteria. Prevalence was higher for women versus men and blacks versus whites; these appeared independent. Loss of SCV was observed at 1.22% per year, and significantly associated with viremia ‘blips’. Blip magnitudes fit log-normal distributions with means below 50 RNA copies/ml. Conclusion: Our novel observation of higher SCV prevalence in women and blacks is consistent with prior studies of typical chronic infection. Viremia blips correspond to greater risk of loss of SCV, likely reflecting higher set-point viremia under the limit of detection. Our findings suggest that SCV represents an extreme along a continuum of HIV-1 infection, and not qualitative difference.Keywords
This publication has 33 references indexed in Scilit:
- Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairsNature Communications, 2012
- Sex, Race, and Geographic Region Influence Clinical Outcomes Following Primary HIV-1 InfectionThe Journal of Infectious Diseases, 2011
- The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide PresentationScience, 2010
- Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History StudyThe Journal of Infectious Diseases, 2009
- Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIVAIDS, 2009
- Genetic Characterization of Human Immunodeficiency Virus Type 1 in Elite Controllers: Lack of Gross Genetic Defects or Common Amino Acid ChangesJournal of Virology, 2008
- A Comparison of Viral Loads between HIV‐1–Infected Elite Suppressors and Individuals Who Receive Suppressive Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2008
- A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1Science, 2007
- ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy ViremiaPLOS Pathogens, 2007
- Isolation and Characterization of Replication-Competent Human Immunodeficiency Virus Type 1 from a Subset of Elite SuppressorsJournal of Virology, 2007